Error-promoting DNA synthesis in ovarian cancer cells

Gynecologic Oncology

Volumn 131, Issue 1, 2013, Pages 198-206

  Dai, Heqiao ^a   Hickey, Robert J ^b   Liu, Jianying ^a   Bigsby, Robert M ^a   Lanner, Carita ^a,c   Malkas, Linda H ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

Author keywords

DNA replication; Multiprotein complex; Ovarian cancer; Replication fidelity

Indexed keywords

DEOXYADENOSINE TRIPHOSPHATE; DEOXYCYTIDINE TRIPHOSPHATE; DEOXYGUANOSINE TRIPHOSPHATE; DNA POLYMERASE; PLASMID DNA; PURINE NUCLEOTIDE; PYRIMIDINE NUCLEOTIDE; SINGLE STRANDED DNA; VIRUS LARGE T ANTIGEN;

ARTICLE; BACTERIOPHAGE T4; BASE MISPAIRING; BINDING AFFINITY; CANCER CELL; CONTROLLED STUDY; DNA ISOLATION; DNA REPLICATION; DNA TEMPLATE; EPITHELIUM CELL; GENE; GENETIC DAMAGE; HUMAN; HUMAN CELL; KINETICS; LAC Z ALPHA GENE; MUTATION RATE; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 84885302807     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.06.022     Document Type: Article

References (44)

1. Salk JJ, Fox EJ, Loeb LA. Mutational heterogeneity in human cancers: origin and consequences. Annu Rev Pathol 2010;5: 51-75.
2. Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 1999;399(6737): 700-4.
3. Kunkel TA. Considering the cancer consequences of altered DNA polymerase function. Cancer Cell 2003;3(2): 105-10.
4. Gallion HH, Powell DE, Morrow JK, Pieretti M, Case E, Turker MS, et al. Chromosome abnormalities in human epithelial ovarian malignancies. Gynecol Oncol 1990;38(3): 473-7.
5. Haapasalo H, Atkin NB, Collan Y, Pesonen E, Paljarvi L. Tumour ploidy,morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations. Anal Cell Pathol 1991;3(5): 261-71.
6. Kulkarni AA, Loddo M, Leo E, Rashid M, Eward KL, Fanshawe TR, et al. DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. Clin Cancer Res 2007;13(20): 6153-61.
7. Kaern J, Trope CG, Kristensen GB, Abeler VM, Pettersen EO. DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer 1993;3(6): 349-58.
8. Ozalp S, Yalcin OT, Gulbas Z, Tanir HM, Minsin T. Effect of cellularDNA content on the prognosis of epithelial ovarian cancers. Gynecol Obstet Invest 2001;52(2): 93-7.
9. Pfisterer J, Kommoss F, Sauerbrei W, Rens H, duBois A, Jiechle-Schwarz M, et al. Cellular DNA content and survival in advanced ovarian carcinoma. Cancer 1994;74(9): 2509-15.
10. Reles AE, Gee C, Schellschmidt I, Schmider A, Unger M, Friedmann W, et al. Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry. Gynecol Oncol 1998;71(1): 3-13.
11. Kallioniemi OP, Punnonen R,Mattila J, LehtinenM, Koivula T, et al. Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer. Cancer 1988;61(2): 334-9.
12. Kallioniemi OP, Mattila J, Punnonen R, Koivula T. DNA ploidy level and cell cycle distribution in ovarian cancer: relation to histopathological features of the tumor. Int J Gynecol Pathol 1988;7(1): 1-11.
13. Loeb LA, Bielas JH, Beckman RA. Cancers exhibit amutator phenotype: clinical implications. Cancer Res 2008;68(10):3551-7 [discussion 3557].
14. Applegren N, Hickey RJ, Kleinschmidt AM, Zhou Q, Coll J,Wills P, et al. Further characterization of the human cell multiprotein DNA replication complex. J Cell Biochem 1995;59(1): 91-107.
15. Coll JM, Sekowski JW, Hickey RJ, Schnaper L, Yue W, Brodie AM, et al. The human breast cell DNA synthesom: its purification from tumor tissue and cell culture. Oncol Res 1996;8(10-11): 435-47.
16. DaiH, Liu J,Malkas LH,Hickey RJ. Characterization of RNA primers synthesized by the human breast cancer cell DNA synthesome. J Cell Biochem 2009;106(5): 798-811.
17. Jiang HY, Hickey RJ, Abdel-Aziz W, Tom TD, Wills PW, Liu J, et al. Human cell DNA replication is mediated by a discrete multiprotein complex. J Cell Biochem 2002;85(4): 762-74.
18. Lin S, Hickey R, Malkas L. The biochemical status of the DNA synthesome can distinguish between permanent and temporary cell growth arrest. Cell Growth Differ 1997;8(12): 1359-69.
19. Malkas LH, Hickey RJ, Li C, Pedersen N, Baril EF. A 21S enzyme complex from HeLa cells that functions in simian virus 40 DNA replication in vitro. Biochemistry 1990;29(27): 6362-74.
20. Ahluwalia A, Hurteau JA, Bigsby RM, Nephew KP. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells. Gynecol Oncol 2001;82(2): 299-304.
21. Ahluwalia A, Yan P, Hurteau JA, Bigsby RM, Jung SH, Huang TH, et al. DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization. Gynecol Oncol 2001;82(2): 261-8.
22. Hurteau JA, Allison BM, Brutkiewicz SA, Goebl MG, Heilman DK, Bigsby RM, et al. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer. Gynecol Oncol 2001;83(2): 292-8.
23. Song J, Shih Ie M, Salani R, ChanDW, Zhang Z. Annexin XI is associatedwith cisplatin resistance and related to tumor recurrence in ovarian cancer patients. Clin Cancer Res 2007;13(22 Pt 1): 6842-9.
24. Bast Jr RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68(5): 1331-7.
25. Geisinger KR, Kute TE, Pettenati MJ, Welander CE, Dennard Y, Collins L, et al. Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer 1989;63(2): 280-8.
26. Dai H, Liu J, Malkas LH, Catalano J, Alagharu S,Hickey RJ, et al. Chromiumreduces the in vitro activity and fidelity of DNA replication mediated by the human cell DNA synthesome. Toxicol Appl Pharmacol 2009;236(2): 154-65.
27. Sekowski JW, Malkas LH, Schnaper L, Bechtel PE, Long BJ, Hickey RJ, et al. Human breast cancer cells contain an error-prone DNA replication apparatus. Cancer Res 1998;58(15): 3259-63.
28. Creighton S, Goodman MF. Gel kinetic analysis of DNA polymerase fidelity in the presence of proofreading using bacteriophage T4 DNA polymerase. J Biol Chem 1995;270(9): 4759-74.
29. Hanahan D,Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144(5): 646-74.
30. SjoblomT, Jones S,Wood LD, ParsonsDW, Lin J, Barber TD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314(5797): 268-74.
31. Check Hayden E. Cancer complexity slows quest for cure. Nature 2008;455(7210): 148.
32. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, et al. A census of human cancer genes. Nat Rev Cancer 2004;4(3): 177-83.
33. MurdochWJ. Carcinogenic potential of ovulatory genotoxicity. Biol Reprod 2005;73(4): 586-90.
34. Suzuki, et al. DNA replication error is frequent in ovarian granulosa cell tumors. Cancer Genet Cytogenet 2000;122: 55-8.
35. Hirst, Brown. Detection of the replication error phenotype in ovarian cancer-PCR analysis of microsatellite instability. Methods Mol Biol 2001;39: 375-82.
36. Zhai QJ, Rosen DG, Lu K, Liu J. Loss of DNA mismatch repair protein hMSH6 in ovarian cancer is histotype-specific. Int J Clin Exp Pathol 2008;1: 502-9.
37. Auersperg N. The origin of ovarian cancers-hypotheses and controversies. Front Biosci (Schol Ed) 2013;5: 709-19.
38. Burhans WC, Carr AM, Wahl GM. DNA replication and cancer. In: DePamphilis M, editor. DNA replication and human disease. New York: Cold Springs Harbor; 2006.
39. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, et al. Oncogeneinduced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006;444(7119): 633-7.
40. Allen C, Ashley AK, Hromas R, Nickoloff JA. More forks on the road to replication stress recovery. J Mol Cell Biol 2011;3(1): 4-12.
41. Bartek J,MistrikM, Bartkova J. Thresholds of replication stress signaling in cancer development and treatment. Nat Struct Mol Biol 2012;19(1): 5-7.
42. Zheng L, Dai H, Zhou M, Li X, Liu C, Guo Z, et al. Polyploid cells rewire DNA damage response networks to overcome replication stress-induced barriers for tumour progression. Nat Commun 2012;3:815.
43. Sandoval JA, Grosfeld JL, Hickey RJ,Malkas LH. Structural analysis of the human neuroblastoma DNA replication complex: insights into faulty proliferation. J Pediatr Surg 2006;41: 266-70.
44. Loeb LA. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer 2011;6: 450-7.